Plasma amitriptyline level after acute administration, and driving performance in healthy volunteers

Psychiatry and Clinical Neurosciences

Volumn 62, Issue 5, 2008, Pages 610-616

  Iwamoto, Kunihiro ^a   Kawamura, Yukiko ^b   Takahashi, Masahiro ^a   Uchiyama, Yuji ^c   Ebe, Kazutoshi ^c   Yoshida, Keizo ^a   Iidaka, Tetsuya ^a   Noda, Yukihiro ^b   Ozaki, Norio ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

^c Rd Management Section   (Japan)

Author keywords

Amitriptyline; Antidepressants; Automobile driving; Cognition; Drug monitoring

Indexed keywords

AMITRIPTYLINE;

ACUTE DRUG ADMINISTRATION; ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; DRIVING ABILITY; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; QUESTIONNAIRE; TASK PERFORMANCE; VOLUNTEER;

ADULT; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; AROUSAL; ATTENTION; AUTOMOBILE DRIVING; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE;

EID: 53149153931     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2008.01838.x     Document Type: Article

References (37)

1. Baumann P, Hiemke C, Ulrich S et al. The AGNP-TDM expert group consensus guidelines: Therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 2004 37 : 243 265.
2. Task Force on the Use of Laboratory Tests in Psychiatry. Tricyclic antidepressants: Blood level measurements and clinical outcome: An APA Task Force report. Am. J. Psychiatry 1985 142 : 155 162.
3. Orsulak PJ. Therapeutic monitoring of antidepressant drugs: Guidelines updated. Ther. Drug Monit. 1989 11 : 497 507.
4. Preskorn SH, Fast GA. Therapeutic drug monitoring for antidepressants: Efficacy, safety, and cost effectiveness. J. Clin. Psychiatry 1991 52 (Suppl 23 33.
5. Perry PJ, Zeilmann C, Arndt S. Tricyclic antidepressant concentrations in plasma: An estimate of their sensitivity and specificity as a predictor of response. J. Clin. Psychopharmacol. 1994 14 : 230 240.
6. Rodriguez de la Torre B, Dreher J, Malevany I et al. Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients. Ther. Drug Monit. 2001 23 : 435 440.
7. Ulrich S, Lauter J. Comprehensive survey of the relationship between serum concentration and therapeutic effect of amitriptyline in depression. Clin. Pharmacokinet. 2002 41 : 853 876.
8. Ray WA, Fought RL, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am. J. Epidemiol. 1992 136 : 873 883.
9. Leveille SG, Buchner DM, Koepsell TD, McCloskey LW, Wolf ME, Wagner EH. Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology 1994 5 : 591 598.
10. Ramaekers JG. Antidepressants and driver impairment: Empirical evidence from a standard on-the-road test. J. Clin. Psychiatry 2003 64 : 20 29.
11. Robbe HW, O'Hanlon JF. Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers. Eur. Neuropsychopharmacol. 1995 5 : 35 42.
12. Hindmarch I, Subhan Z, Stoker MJ. The effects of zimeldine and amitriptyline on car driving and psychomotor performance. Acta Psychiatr. Scand. Suppl. 1983 308 : 141 146.
13. Bye C, Clubley M, Peck AW. Drowsiness, impaired performance and tricyclic antidepressants drugs. Br. J. Clin. Pharmacol. 1978 6 : 155 162.
14. Crome P, Newman B. A comparison of the effects of single doses of mianserin and amitriptyline on psychomotor tests in normal volunteers. J. Int. Med. Res. 1978 6 : 430 434.
15. Peck AW, Bye CE, Clubley M, Henson T, Riddington C. A comparison of bupropion hydrochloride with dexamphetamine and amitriptyline in healthy subjects. Br. J. Clin. Pharmacol. 1979 7 : 469 478.
16. Ogura C, Kishimoto A, Mizukawa R et al. Influence of single doses of dothiepin and amitriptyline on physiological measures and psychomotor performance in normal young and elderly volunteers. Neuropsychobiology 1983 10 : 103 107.
17. Tiller JW. Antidepressants, alcohol and psychomotor performance. Acta Psychiatr. Scand. Suppl. 1990 360 : 13 17.
18. Kinirons MT, Jackson SH, Kalra L, Trevit RT, Swift CG. Computerised psychomotor performance testing: A comparative study of the single dose pharmacodynamics of minaprine and amitriptyline in young and elderly subjects. Br. J. Clin. Pharmacol. 1993 36 : 376 379.
19. Nathan PJ, Sitaram G, Stough C, Silberstein RB, Sali A. Serotonin, noradrenaline and cognitive function: A preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor. Behav. Pharmacol. 2000 11 : 639 642.
20. Iwamoto K, Takahashi M, Nakamura Y et al. The effects of acute treatment with paroxetine, amitriptyline, and placebo on driving performance and cognitive function in healthy Japanese subjects: A double-blind crossover trial. Hum. Psychopharmacol. 2008 23 : 399 407.
21. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: A new approach. Psychophysiology 1973 10 : 431 436.
22. Jiang ZP, Shu Y, Chen XP et al. The role of CYP2C19 in amitriptyline N-demethylation in Chinese subjects. Eur. J. Clin. Pharmacol. 2002 58 : 109 113.
23. Duverneuil C, de la Grandmaison GL, de Mazancourt P, Alvarez JC. A high-performance liquid chromatography method with photodiode-array UV detection for therapeutic drug monitoring of the nontricyclic antidepressant drugs. Ther. Drug Monit. 2003 25 : 565 573.
24. Halling J, Weihe P, Brosen K. The CYP2D6 polymorphism in relation to the metabolism of amitriptyline and nortriptyline in the Faroese population. Br. J. Clin. Pharmacol. 2008 65 : 134 138.
25. O'Hanlon JF, Haak TW, Blaauw GJ, Riemersma JB. Diazepam impairs lateral position control in highway driving. Science 1982 217 : 79 81.
26. O'Hanlon JF. Driving performance under the influence of drugs: Rationale for, and application of, a new test. Br. J. Clin. Pharmacol. 1984 18 (Suppl. 1 121S 129S.
27. Uchiyama Y, Ebe K, Kozato A, Okada T, Sadato N. The neural substrates of driving at a safe distance: A functional MRI study. Neurosci. Lett. 2003 352 : 199 202.
28. Heaton RK. The Wisconsin Card Sorting Test (Manual). Psychological Assessment Resources, Odessa, FL, 1981.
29. Kashima H, Honda T, Kato M et al. Neuropsychological investigation on chronic schizophrenia-aspect of its frontal functions. In : Takahashi R, Flor-Henry P, Gruzelier J, Niwa S (eds). Cerebral Dynamics, Laterality and Psychopathology. Elsevier, Amsterdam, 1987 337 345.
30. Cornblatt BA, Risch NJ, Faris G, Friedman D, Erlenmeyer-Kimling L. The continuous performance test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Res. 1988 26 : 223 238.
31. Callicott JH, Bertolino A, Mattay VS et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb. Cortex 2000 10 : 1078 1092.
32. Callicott JH, Egan MF, Mattay VS et al. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am. J. Psychiatry 2003 160 : 709 719.
33. van Laar MW, van Willigenburg AP, Volkerts ER. Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects. J. Clin. Psychopharmacol. 1995 15 : 30 40.
34. Murphy FC, Michael A, Robbins TW, Sahakian BJ. Neuropsychological impairment in patients with major depressive disorder: The effects of feedback on task performance. Psychol. Med. 2003 33 : 455 467.
35. Porter RJ, Gallagher P, Thompson JM, Young AH. Neurocognitive impairment in drug-free patients with major depressive disorder. Br. J. Psychiatry 2003 182 : 214 220.
36. Airaksinen E, Larsson M, Lundberg I, Forsell Y. Cognitive functions in depressive disorders: Evidence from a population-based study. Psychol. Med. 2004 34 : 83 91.
37. Richardson JS, Keegan DL, Bowen RC et al. Verbal learning by major depressive disorder patients during treatment with fluoxetine or amitriptyline. Int. Clin. Psychopharmacol. 1994 9 : 35 40.